Literature DB >> 7447423

Pharmacokinetic comparison of cefroxadin (CGP 9000) and cephalexin by simultaneous administration to humans.

J B Lecaillon, J L Hirtz, J P Schoeller, G Humbert, W Vischer.   

Abstract

The pharmacokinetic parameters of cefroxadin and cephalexin were compared after simultaneous oral administration of the two cephalosporins to 21 subjects. The influence of the dose, the formulation, and food intake on these parameters was investigated. Both drugs were equally well absorbed from all of the tested formulations; identical percentages of the dose were recovered in the urine in all cases. The elimination half-life of cefroxadin and, consequently, the area under the plasma concentration-time curve were about 10% less than those of cephalexin. Plasma concentrations and cumulative excretion curves of the two drugs were almost superimposable. Food intake had the same effect on both drugs; absorption was slowed, but the amounts absorbed were almost the same as those in fasted subjects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7447423      PMCID: PMC284071          DOI: 10.1128/AAC.18.5.656

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  8 in total

Review 1.  Pharmacokinetics and clinical use of cephalosporin antibiotics.

Authors:  C H Nightingale; D S Greene; R Quintiliani
Journal:  J Pharm Sci       Date:  1975-12       Impact factor: 3.534

2.  CGP 9000: a new orally active, broad-spectrum cephalosporin.

Authors:  O Zak; W A Vischer; C Schenk; W Tosch; W Zimmermann; J Regös; E R Suter; F Kradolfer; J Gelzer
Journal:  J Antibiot (Tokyo)       Date:  1976-06       Impact factor: 2.649

Review 3.  Cephalexin.

Authors:  R S Griffith; H R Black
Journal:  Med Clin North Am       Date:  1970-09       Impact factor: 5.456

4.  Penetration of four cephalosporins into tissue fluid in man.

Authors:  A P Gillett
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

5.  Pharmacokinetics of oral cephalosporins: cephradine cephalexin.

Authors:  E Finkelstein; R Quintiliani; R Lee; A Bracci; C H Nightingale
Journal:  J Pharm Sci       Date:  1978-10       Impact factor: 3.534

6.  [Pharmacokinetic comparative studies on the resorption of 3 new cephalosporins].

Authors:  H Lode; R Stahlmann; G Dzwillo; P Koeppe
Journal:  Verh Dtsch Ges Inn Med       Date:  1978

7.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

8.  In vitro activity against Escherichia coli of CGP 9000, a new oral cephalosporin.

Authors:  D Greenwood
Journal:  J Antibiot (Tokyo)       Date:  1978-07       Impact factor: 2.649

  8 in total
  5 in total

1.  A randomized double-blind investigation of cefroxadine (CGP 9000) versus cephalexin in urinary tract infection.

Authors:  J Hess; P Gammelgaard; B Holst; F Rasmussen; V F Thomsen
Journal:  Infection       Date:  1984 Jul-Aug       Impact factor: 3.553

2.  Pharmacokinetics of cefroxadin (CGP 9000) in man.

Authors:  A Gerardin; J B Lecaillon; J P Schoeller; G Humbert; J Guibert
Journal:  J Pharmacokinet Biopharm       Date:  1982-02

3.  Interethnic differences of PEPT2 (SLC15A2) polymorphism distribution and associations with cephalexin pharmacokinetics in healthy Asian subjects.

Authors:  Rui Liu; Audrey May Yi Tang; Yen Ling Tan; Lie Michael George Limenta; Edmund Jon Deoon Lee
Journal:  Eur J Clin Pharmacol       Date:  2008-09-03       Impact factor: 2.953

4.  On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant Food.

Authors:  Marina Statelova; Konstantinos Goumas; Nikoletta Fotaki; René Holm; Mira Symillides; Christos Reppas; Maria Vertzoni
Journal:  AAPS J       Date:  2019-12-02       Impact factor: 4.009

5.  Does the placebo effect modulate drug bioavailability? Randomized cross-over studies of three drugs.

Authors:  Muhammad M Hammami; Ahmed Yusuf; Faduma S Shire; Rajaa Hussein; Reem Al-Swayeh
Journal:  J Negat Results Biomed       Date:  2017-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.